Table of Contents Author Guidelines Submit a Manuscript
Corrigendum

A corrigendum for this article has been published. To view the corrigendum, please click here.

Oxidative Medicine and Cellular Longevity
Volume 2014 (2014), Article ID 313602, 18 pages
http://dx.doi.org/10.1155/2014/313602
Research Article

Reduced Oxidative Stress Contributes to the Lipid Lowering Effects of Isoquercitrin in Free Fatty Acids Induced Hepatocytes

National Center for Drug Screening and State Key Laboratory of Natural Medicines, China Pharmaceutical University, No. 24 Tongjiaxiang, Nanjing, Jiangsu 210009, China

Received 1 June 2014; Accepted 3 July 2014; Published 22 October 2014

Academic Editor: Francisco Javier Romero

Copyright © 2014 Waseem Hassan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. P. Day, “Pathogenesis of steatohepatitis,” Bailliere's Best Practice and Research in Clinical Gastroenterology, vol. 16, no. 5, pp. 663–678, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. M. A. Lanaspa, L. G. Sanchez-Lozada, Y. Choi et al., “Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and -independent fatty liver,” The Journal of Biological Chemistry, vol. 287, no. 48, pp. 40732–40744, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Espinosa, “Prevention of liver steatosis through fish oil supplementation: correlation of oxidative stress with insulin resistance and liver fatty acid content,” Archivos Latinoamericanos de Nutrición, vol. 63, no. 1, pp. 29–36, 2013. View at Google Scholar
  4. K. Sivaraman, G. P. Senthilkumar, P. Sankar, and Z. Bobby, “Attenuation of oxidative stress, inflammation and insulin resistance by allium sativum in fructose-fed male rats,” Journal of Clinical and Diagnostic Research, vol. 7, no. 9, pp. 1860–1862, 1860. View at Publisher · View at Google Scholar
  5. B. Wang, J. Sun, X. Li et al., “Resveratrol prevents suppression of regulatory T-cell production, oxidative stress, and inflammation of mice prone or resistant to high-fat diet-induced obesity,” Nutrition Research, vol. 33, no. 11, pp. 971–981, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. M. D. Wheeler, H. Kono, M. Yin et al., “The role of kupffer cell oxidant production in early ethanol-induced liver disease,” Free Radical Biology & Medicine, vol. 31, no. 12, pp. 1544–1549, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Kogiso, Y. Moriyoshi, and H. Nagahara, “Clinical significance of fatty liver associated with metabolic syndrome,” Hepatology Research, vol. 37, no. 9, pp. 711–721, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Gastaldelli, M. Kozakova, K. Højlund et al., “Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population,” Hepatology, vol. 49, no. 5, pp. 1537–1544, 2009. View at Publisher · View at Google Scholar
  9. J. H. do Nascimento, M. Epifanio, R. B. Soder, and M. Baldisserotto, “MRI-diagnosed nonalcoholic fatty liver disease is correlated to insulin resistance in adolescents,” Academic Radiology, vol. 20, no. 11, pp. 1436–1442, 2013. View at Google Scholar
  10. C. C. Liao, T. T. Ou, C. H. Wu, and C. J. Wang, “Prevention of diet-induced hyperlipidemia and obesity by caffeic acid in C57BL/6 mice through regulation of hepatic lipogenesis gene expression,” Journal of Agricultural and Food Chemistry, vol. 61, no. 46, pp. 11082–11088, 2013. View at Publisher · View at Google Scholar
  11. H. Chen, “Adiponectin activates the AMPK signaling pathway to regulate lipid metabolism in bovine hepatocytes,” The Journal of Steroid Biochemistry and Molecular Biology, vol. 138, pp. 445–454, 2013. View at Google Scholar
  12. M. Enjoji, K. Yasutake, M. Kohjima, and M. Nakamuta, “Nutrition and nonalcoholic fatty liver disease: the significance of cholesterol,” International Journal of Hepatology, vol. 2012, Article ID 925807, 6 pages, 2012. View at Publisher · View at Google Scholar
  13. N. Ruderman and M. Prentki, “AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome,” Nature Reviews Drug Discovery, vol. 3, no. 4, pp. 340–351, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Granica, M. E. Czerwińska, B. Zyżyńska-Granica, and A. K. Kiss, “Antioxidant and anti-inflammatory flavonol glucuronides from Polygonum aviculare L.,” Fitoterapia, vol. 91, pp. 180–188, 2013. View at Google Scholar
  15. S. Chirumbolo, “The role of quercetin, flavonols and flavones in modulating inflammatory cell function,” Inflammation and Allergy-Drug Targets, vol. 9, no. 4, pp. 263–285, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Benmalek, O. A. Yahia, A. Belkebir, and M. Fardeau, “Anti-microbial and anti-oxidant activities of illicium verum, Crataegus oxyacantha ssp monogyna and Allium cepa red and white varieties,” Bioengineered, vol. 4, no. 4, pp. 244–248, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. H. L. Liu, W. B. Jiang, and M. X. Xie, “Flavonoids: Recent advances as anticancer drugs,” Recent Patents on Anti-Cancer Drug Discovery, vol. 5, no. 2, pp. 152–164, 2010. View at Google Scholar · View at Scopus
  18. K. Vidyalakshmi, P. Kamalakannan, S. Viswanathan, and S. Ramaswamy, “Anti-inflammatory effect of certain dihydroxy flavones and the mechanisms involved,” Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, vol. 11, no. 3, pp. 253–261, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Li, C. Yuan, C. Dong, S. Shuang, and M. M. F. Choi, “In vivo antioxidative effect of isoquercitrin on cadmium-induced oxidative damage to mouse liver and kidney,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 383, no. 5, pp. 437–445, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. S. H. Jung, B. J. Kim, E. H. Lee, and N. N. Osborne, “Isoquercitrin is the most effective antioxidant in the plant Thuja orientalis and able to counteract oxidative-induced damage to a transformed cell line (RGC-5 cells),” Neurochemistry International, vol. 57, no. 7, pp. 713–721, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. A. W. Boots, M. Drent, V. C. J. de Boer, A. Bast, and G. R. M. M. Haenen, “Quercetin reduces markers of oxidative stress and inflammation in sarcoidosis,” Clinical Nutrition, vol. 30, no. 4, pp. 506–512, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. E. F. Hoek-van den Hil, J. Keijer, A. Bunschoten et al., “Quercetin induces hepatic lipid omega-oxidation and lowers serum lipid levels in mice,” PLoS ONE, vol. 8, no. 1, Article ID e51588, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. X. D. Guo, D. Zhang, X. Gao et al., “Quercetin and quercetin-3-O-glucuronide are equally effective in ameliorating endothelial insulin resistance through inhibition of reactive oxygen species-associated inflammation,” Molecular Nutrition and Food Research, vol. 57, no. 6, pp. 1037–1045, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. S. H. Lee, B. Kim, M. J. Oh et al., “Persicaria hydropiper (L.) spach and its flavonoid components, isoquercitrin and isorhamnetin, activate the Wnt/-βcatenin pathway and inhibit adipocyte differentiation of 3T3-L1 cells,” Phytotherapy Research, vol. 25, no. 11, pp. 1629–1635, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. E. Karaskov, C. Scott, L. Zhang, T. Teodoro, M. Ravazzola, and A. Volchuk, “Chronic palmitate but not oleate exposure induces endoplasmic reticulum stress, which may contribute to INS-1 pancreatic β-cell apoptosis,” Endocrinology, vol. 147, no. 7, pp. 3398–3407, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. Akazawa, S. Cazanave, J. L. Mott et al., “Palmitoleate attenuates palmitate-induced Bim and PUMA up-regulation and hepatocyte lipoapoptosis,” Journal of Hepatology, vol. 52, no. 4, pp. 586–593, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. E. J. Hong, M.-P. Levasseur, C. R. Dufour, M.-C. Perry, and V. Giguere, “Loss of estrogen-related receptor alpha promotes hepatocarcinogenesis development via metabolic and inflammatory disturbances,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 44, pp. 17975–17980, 2013. View at Google Scholar
  28. N. C. Chavez-Tapia, N. Rosso, and C. Tiribelli, “Effect of intracellular lipid accumulation in a new model of non-alcoholic fatty liver disease,” BMC Gastroenterology, vol. 12, article 20, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. W. Cui, S. L. Chen, and K. Hu, “Quantification and mechanisms of oleic acid-induced steatosis in HepG2 cells,” American Journal of Translational Research, vol. 2, no. 1, pp. 95–104, 2010. View at Google Scholar · View at Scopus
  30. S. A. Bustin, V. Benes, J. A. Garson et al., “The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments,” Clinical Chemistry, vol. 55, no. 4, pp. 611–622, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. China Pharmacopoeia Committee, Pharmacopoeia of the People's Republic of China, The First Division of 2010 Edition, Chinese Medicine and Technology Publishing House, Beijing, China, 2010.
  32. K. Motoyama, H. Koyama, M. Moriwaki et al., “Atheroprotective and plaque-stabilizing effects of enzymatically modified isoquercitrin in atherogenic apoE-deficient mice,” Nutrition, vol. 25, no. 4, pp. 421–427, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Lee, H. Park, Y. Notsu et al., “Effects of hyperin, isoquercitrin and quercetin on lipopolysaccharide- induced nitrite production in rat peritoneal macrophages,” Phytotherapy Research, vol. 22, no. 11, pp. 1552–1556, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Ekstedt, L. E. Franzén, U. L. Mathiesen, M. Holmqvist, G. Bodemar, and S. Kechagias, “Statins in non-alcoholic fatty liver disease and chronically elevated liver enzymes: a histopathological follow-up study,” Journal of Hepatology, vol. 47, no. 1, pp. 135–141, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Xiao, R. Guo, M. L. Fung, E. C. Liong, and G. L. Tipoe, “Therapeutic approaches to non-alcoholic fatty liver disease: past achievements and future challenges,” Hepatobiliary and Pancreatic Diseases International, vol. 12, no. 2, pp. 125–135, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. T. Ábel, J. Fehér, E. Dinya, M. G. Eldin, and A. Kovács, “Safety and efficacy of combined ezetimibe/simvastatin treatment and simvastatin monotherapy in patients with non-alcoholic fatty liver disease,” Medical Science Monitor, vol. 15, no. 12, pp. MS6–MS11, 2009. View at Google Scholar · View at Scopus
  37. P. Loria, A. Lonardo, and F. Anania, “Liver and diabetes. A vicious circle,” Hepatology Research, vol. 43, no. 1, pp. 51–64, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. K. Sugimoto and Y. Takei, “Clinicopathological features of non-alcoholic fatty liver disease,” Hepatology Research, vol. 41, no. 10, pp. 911–920, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. M. C. Garcia, M. Amankwa-Sakyi, and T. J. Flynn, “Cellular glutathione in fatty liver in vitro models,” Toxicology in Vitro, vol. 25, no. 7, pp. 1501–1506, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. D. E. Brumbaugh and J. E. Friedman, “Developmental origins of nonalcoholic fatty liver disease,” Pediatric Research, vol. 75, no. 1-2, pp. 140–147, 2014. View at Google Scholar
  41. L. Huc, A. Lemarié, F. Guéraud, and C. Héliès-Toussaint, “Low concentrations of bisphenol A induce lipid accumulation mediated by the production of reactive oxygen species in the mitochondria of HepG2 cells,” Toxicology in Vitro, vol. 26, no. 5, pp. 709–717, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. G. Fusai, G. K. Glantzounis, T. Hafez et al., “N-acetylcysteine ameliorates the late phase of liver ischaemia/reperfusion injury in the rabbit with hepatic steatosis,” Clinical Science, vol. 109, no. 5, pp. 465–473, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. S. Samuhasaneeto, D. Thong-Ngam, O. Kulaputana, S. Patumraj, and N. Klaikeaw, “Effects of N-acetylcysteine on oxidative stress in rats with non-alcoholic steatohepatitis,” Journal of the Medical Association of Thailand, vol. 90, no. 4, pp. 788–797, 2007. View at Google Scholar · View at Scopus
  44. J. N. Baumgardner, K. Shankar, L. Hennings, E. Albano, T. M. Badger, and M. J. J. Ronis, “N-acetylcysteine attenuates progression of liver pathology in a rat model of nonalcoholic steatohepatitis,” Journal of Nutrition, vol. 138, no. 10, pp. 1872–1879, 2008. View at Google Scholar · View at Scopus
  45. N. A. Shirwany and M. Zou, “AMPK in cardiovascular health and disease,” Acta Pharmacologica Sinica, vol. 31, no. 9, pp. 1075–1084, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. W. Huang, A. Metlakunta, N. Dedousis et al., “Depletion of liver kupffer cells prevents the development of diet-induced hepatic steatosis and insulin resistance,” Diabetes, vol. 59, no. 2, pp. 347–357, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. W. Hassan, L. Ding, R. Y. Gao, J. Liu, and J. Shang, “Interleukin-6 signal transduction and its role in hepatic lipid metabolic disorders,” Cytokine, vol. 66, no. 2, pp. 133–142, 2014. View at Google Scholar
  48. O. Nov, H. Shapiro, H. Ovadia et al., “Interleukin-1β regulates fat-liver crosstalk in obesity by auto- paracrine modulation of adipose tissue inflammation and expandability,” PLoS ONE, vol. 8, no. 1, Article ID e53626, 2013. View at Publisher · View at Google Scholar · View at Scopus